Evidence map›Paper›PMID 25002937›Full record

ArticleOrthopedic reviews2014

Elastofibroma: clinical results after resection of a rare tumor entity.

Hakan Pilge, Tobias Hesper, Boris Michael Holzapfel, Peter Michael Prodinger, Melanie Straub, Rüdiger Krauspe

Open access · goldAbstract read
In one paragraph

Article in Orthopedic reviews, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Elastofibroma dorsi: a histochemical and immunohistochemical study.European journal of histochemistry : EJH · 2015
    Article
  5. Elastofibroma: An Uncommon Tumor Revisited.Journal of cutaneous and aesthetic surgery
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Hakan PilgeDepartment of Orthopedics, University Clinic Dusseldorf , Germany.
Tobias HesperDepartment of Orthopedics, University Clinic Dusseldorf , Germany.
Boris Michael HolzapfelInstitute of Health and Biomedical Innovation, Queensland University of Technology , Brisbane, Australia.
Peter Michael ProdingerDepartment of Orthopedics, Technical University of Munich , Germany.
Melanie StraubDepartment of Pathology, Technical University of Munich , Germany.
Rüdiger KrauspeDepartment of Orthopedics, University Clinic Dusseldorf , Germany.
Queensland University of Technology · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Elastofibroma (EF) is a benign proliferation of connective tissue and is typically located at the dorsal thoracic wall. Most patients complain about pain during motion in the shoulder girdle. The aim of our study was to evaluate the outcome after surgical treatment of EF. This study provides an overview of typical clinical findings, diagnostics and pathogenesis of this rare entity. In this retrospective study we analyzed data of 12 patients (6 male, 6 female) with EF treated in our institution between 2004 and 2012. The mean follow-up was 4.7 years (range: 5 months to 7.5 years). All tumors were found to be unilateral and all patients had a negative medical history for EF. Visual analogue scale and range of motion (ROM) was documented pre- and postoperatively. In all patients indication for surgical resection was pain or uneasiness during movement. There was no statistically significant difference in ROM of the shoulder between pre- and postoperatively but all patients reported significantly less pain after surgical resection. Patients benefited from tumor resection by a significant reduction of pain levels and improvement of the motion-dependent discomfort.

Indexed as

elastofibromaorphan diseasesurgical outcometumor

Identifiers

PMID25002937
PMCPMC4083310
OpenAlexW1992101340

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.